Episode Details
Back to EpisodesMirtazapine Shows Promise in Meth Treatment
Published 6 days, 9 hours ago
Description
A groundbreaking study reveals a potential solution for meth addiction, with the antidepressant mirtazapine reducing meth use by seven days in a twelve-week trial. This could pave the way for approved medication for meth use disorder, currently lacking worldwide. The study, led by Professor Rebecca McKetin, shows promise in easier prescription and improved patient retention due to its mild sedative effect.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/74eab9250dfb09ea